212
Schrammel et al.
nitrosoglutathione as a substrate for ␥-glutamyl transpeptidase. Biochem J 323:
477–481.
Huie RE and Padmaja S (1993) The reaction of NO with superoxide. Free Radical Res
Commun 18:195–199.
Humbert P, Niroomand F, Fischer G, Mayer B, Koesling D, Hinsch K-D, Gausepohl
H, Frank R, Schultz G, and Bo¨hme E (1990) Purification of soluble guanylyl
cyclase from bovine lung by a new immunoaffinity chromatographic method. Eur
J Biochem 190:273–278.
Ignarro LJ (1992) Haem-dependent activation of cytosolic guanylate cyclase by nitric
oxide: a widespread signal transduction mechanism. Biochem Soc Trans 20:465–
469.
Kaiser H, Sold G, Schrader J, and Kreuzer H (1983) Development of tolerance and
peripheral hemodynamic effects of molsidomine, in Nitrates and Nitrate Tolerance
in Angina Pectoris (Kaltenbach M and Kober G, eds.) pp 101–106, Steinkopff,
Darmstadt.
Koesling D, Bo¨hme E, and Schultz G (1991) Guanylyl cyclases, a growing family of
signal transducing enzymes. FASEB J 5:2785–2791.
Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HSV, Sucher NJ, Loscalzo J, Singel DJ,
and Stamler JS (1993) A redox-based mechanism for the neuroprotective and
neurodestructive effects of nitric oxide and related nitroso-compounds. Nature
(Lond) 364:626–632.
Lymar SV and Hurst JK (1995) Rapid reaction between peroxonitrite ion and carbon
dioxide: implications for biological activity. J Am Chem Soc 117:8867–8868.
Mayer B, Pfeiffer S, Schrammel A, Schmidt K, Koesling D, and Brunner F (1998) A
new pathway of nitric oxide/cGMP signaling involving S-nitrosoglutathione. J Biol
Chem 273:3264–3270.
Mayer B, Schrammel A, Klatt P, Koesling D, and Schmidt K (1995) Peroxynitrite-
induced accumulation of cyclic GMP in endothelial cells and stimulation of purified
soluble guanylyl cyclase. Dependence on glutathione and possible role of
S-nitrosation. J Biol Chem 270:17355–17360.
Nikitovic D and Holmgren A (1996) S-nitrosoglutathione is cleaved by the thiore-
doxin system with liberation of glutathione and redox regulating nitric oxide.
J Biol Chem 271:19180–19185.
Noack E and Feelisch M (1989) Molecular aspects underlying the vasodilator action
of molsidomine. J Cardiovasc Pharmacol 14(Suppl. 11):1–5.
Peterson RE and Bollier ME (1955) Spectrophotometric determination of serum
copper with biscyclohexanoneoxalyldihydrazone. Anal Chem 27:1195–1197.
Pfeiffer S, Schrammel A, Schmidt K, and Mayer B (1998) Electrochemical determi-
nation of S-nitrosothiols with a Clark-type nitric oxide electrode. Anal Biochem
258:68–73
the kinetic data. We also acknowledge gratefully the excellent tech-
nical assistance of Ju¨rgen Malkewitz.
References
Beckman JS and Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite:
the good, the bad, and the ugly. Am J Physiol 40:C1424–C1437.
Bo¨hme E, Spies C, and Grossmann G (1982) Wirksamer Metabolit von Molsidomin
und Stimulation der cGMP-Bildung durch Sydnonimine, in Molsidomin: Neue
Aspekte zur Therapie der Ischa¨mischen Herzerkrankung (Bassenge
Schmutzer H, eds) pp 37–44, Urban & Schwarzenberg, Mu¨nchen.
E and
Bohn H and Scho¨nafinger K (1989) Oxygen and oxidation promote the release of
nitric oxide from sydnonimines. J Cardiovasc Pharmacol 14(Suppl. 11): 6–12.
Bridges AB, Scott NA, McNeill GP, Pringle TH, and Belch JJF (1992) Circadian
variation of white blood cell aggregation and free radical indices in men with
ischaemic heart disease. Eur Heart J 13:1632–1636.
Brunelli L, Crow JP, and Beckman JS (1995) The comparative toxicity of nitric oxide
and peroxynitrite to Escherichia coli. Arch Biochem Biophys 316:327–334.
Butler AR and Rhodes P (1997) Chemistry, analysis and biological roles of S-
nitrosothiols. Anal Biochem 249:1–9.
Chevion M, Jiang YD, Harel R, Berenshtein E, Uretzky G, and Kitrossky N (1993)
Copper and iron are mobilized following myocardial ischemia: possible predictive
criteria for tissue injury. Proc Natl Acad Sci USA 90:1102–1106.
Darius H, Ahland B, Ru¨cker W, Klaus W, Peskar BA, and Schro¨r K (1984) The effects
of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggre-
gation, and eicosanoid formation in vitro-inhibition of 12-HPETE biosynthesis.
J Cardiovasc Pharmacol 6:115–121.
Darley-Usmar VM, Hogg N, OЈLeary VJ, and Moncada S (1992) The simultaneous
generation of superoxide and nitric oxide can initiate lipid peroxidation in human
low density lipoproteins. Free Radical Res Commun 14:19–20.
Dicks AP, Swift HR, Williams LH, Butler AR, Al-Sa’doni HH, and Cox BG (1996)
Identification of Cuϩ as the effective reagent in nitric oxide formation from S-
nitrosothiols (RSNO). J Chem Soc Perkin Trans I 2:481–487.
Diehl H and Smith GF (1958) The Copper Reagents: Cuproine, Neocuproine and
Bathocuproine. G. F. Smith, Columbus, OH.
Dimmeler S, Lottspeich F, and Bru¨ne B (1992) Nitric oxide causes ADP-ribosylation
and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 267:
16771–16774.
Feelisch M, Ostrowski J, and Noack E (1989) On the mechanism of NO release from
sydnonimines. J Cardiovasc Pharmacol 14(Suppl. 11):13–22.
Ferrari R, Ceconi C, Curello S, Cargnoni A, Alfieri O, Pardini A, Marzollo P, and
Visioli O (1991) Oxygen free radicals and myocardial damage: protective role of
thiol-containing agents. Am J Med 91:95S–105S.
Saville B (1958) A scheme for the colorimetric determination of microgram amounts
of thiols. Analyst 83:670–672.
Freedman JE, Frei B, Welch GN, and Loscalzo J (1995) Glutathione peroxidase
potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest
96:394–400.
Friebe A, Malkewitz J, Schultz G, and Koesling D (1996) Positive effects of pollution?
Nature (Lond) 382:120.
Gordge MP, Hothersall JS, Neild GH, and Dutra AAN (1996) Role of a copper(I)-
dependent enzyme in the anti-platelet action of S-nitroso-glutathione. Br J Phar-
macol 119:533–538.
Gorren ACF, Schrammel A, Schmidt K, and Mayer B (1996) Decomposition of
S-nitrosoglutathione in the presence of copper and glutathione. Arch Biochem
Biophys 330:219–228.
Schrammel A, Behrends S, Schmidt K, Koesling D, and Mayer B (1996) Character-
ization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of
nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol 50:1–5.
Schultz G and Bo¨hme E (1984) Guanylate cyclase. GTP pyrophosphate-lyase (cycliz-
ing), E. C.4.6.1.2., in Methods of Enzymatic Analysis (Bergmeyer HU, Bergmeyer
J, and Graßl M, eds) pp 379–389, Verlag Chemie, Weinheim.
Thulesius O (1984) Cardiovascular pharmacology of molsidomine, in Vasodilator
Mechanisms (Vanhoute PM and Vatner SF, eds) pp 234–243, Karger, Basel.
Wedel B, Humbert P, Harteneck C, Foerster J, Malkewitz J, Bo¨hme E, Schultz G,
and Koesling D (1994) Mutation of His-105 of the  1-subunit yields a nitric
oxide-insensitive form of soluble guanylyl cyclase. Proc Natl Acad Sci USA 91:
2592–2596.
Grossmann G (1984) Zellula¨re Wirkungsmechanismen von Sydnoniminen - Unter-
suchungen an Thrombozyten und Lo¨slicher Guanylatcyclase. Doctoral Thesis,
University of Heidelberg, Heidelburg, Germany.
Hogg N, Darley-Usmar VM, Wilson MT, and Moncada S (1992) Production of hy-
droxyl radicals from the simultaneous generation of superoxide and nitric oxide.
Biochem J 281:419–424.
Send reprint requests to: Dr. Bernd Mayer, Institut fu¨r Pharmakologie und
Toxikologie, Karl-Franzens-Universita¨t Graz, Universita¨tsplatz 2, A-8010
Graz, Austria. E-mail: mayer@kfungigraz.ac.at
Hogg N, Singh RJ, Konorev E, Joseph J, and Kalyanaraman
B (1997) S-